Become a "Skin Checker" today
Research demonstrates that early detection of skin cancer requires the patient to be more involved. DermDetect provides access to our network of experts via a dedicated APP that allows you to see the professional images we take and results so you can share them with any medical professional. We use cross-polarized filters and high-resolution Dermoscopy. And now we can connect you for a Virtual Conference with an expert that will be able to see your report and you via Zoom!
Studies suggest that up to 70% of skin cancer cases are initially noticed by the patient themselves or their family/friends rather than a medical professional. Additional research shows that survival rates of skin cancers heavily rely on early-stage diagnosis- for example, early-stage melanoma has a survival rate of over 98%. In contrast, melanomas treated at a later stage have a survival rate of only 16%."
In a primary care setting the combination of dermoscopy and short-term SDI reduces the excision or referral of benign pigmented lesions by more then half, while nearly doubling the sensitivity for the diagnosis of melanoma."
Important People are telling us!
What our customers write about us
"If melanoma is diagnosed at this noninvasive stage, the patient will be cured by excision of the primary tumor, but if melanoma becomes invasive, the chance of cure decreases as invasion thickness increases.3
Harald Kittler, MD
Skin cancer is the most common cancer in the United States and worldwide.
1 in 5 Americans will develop skin cancer by the age of 70.
More than 2 people die of skin cancer in the U.S. every hour.
Having 5 or more sunburns doubles your risk for melanoma.
When detected early, the 5-year survival rate for melanoma is 99 percent.
It is good to push your doctor!
It’s estimated that the number of new melanoma cases diagnosed in 2021 will increase by 5.8 percent. 2 The number of melanoma deaths is expected to increase by 4.8 percent in 2021. 2 An estimated 207,390 cases of melanoma will be diagnosed in the U.S. in 2021. Of those, 106,110 cases will be in situ (noninvasive), confined to the epidermis (the top layer of skin), and 101,280 cases will be invasive, penetrating the epidermis into the skin’s second layer (the dermis). Of the invasive cases, 62,260 will be men and 43,850 will be women.2 In the past decade (2011 – 2021), the number of new invasive melanoma cases diagnosed annually increased by 44 percent.2
The definition of insanity is doing the same thing over and over again and expecting a different result.
Welcome to our website
Intelligent Dermatology with A.I. helps you become a "Skin Checker" too.
What the most recent literature says about our approach to aiding you in the early detection of melanoma.
"I have waited a long time for DermDetect to offer services in our area."
"The MoleScope APP is amazing! Now I can connect easily for a Virtual consult with an expert without the travel expenses. I still see my local doctor for treatments if needed. It is good to help your doctor improve your care by getting an expert opinion first!
Albert T. Young
The biopsy reminds me of the history of hysterectomy. DermDetect provides a safe non-invasive proven way to stop those unnecessary cuts on normal tissue. Using Dermoscopy we look for changes over a 90 day period. No change = No biopsy! NEW! We have Virtual Consults with an academic dermatologist that can advise you via Zoom. Fast, convenient, and efficient!
When you combine Dermoscopy with Confocal Imaging, both non-invasive procedures, the number of biopsies drop from 42 to only 2!
Every biopsy leaves a scar and cost approximately $500! We can save you $20K in biopsy cost when you sign-up and pay us to screen your employees!
10 Reasons to monitor your skin starting now!
Frequently Asked Questions
Who is DermDetect?
Founded in 2016, we are an outpatient dermatology imaging service that is available to everyone that is concerned about skin cancer and wants to use the very best technology to improve outcomes.
Does my doctor need to order it?
No. Everyone can participate and register online. Your doctor will be provided free access to DermEngine so you both can review the results together. By doing this together, you may be able to avoid a biopsy on a normal mole and/or detect melanoma in-situ. There are published papers that describe a 50% reduction in normal biopsies and a 50% increase in early detection!
How do I get the results?
We provide a powerful APP that will work on any smartphone or tablet. Before you leave our office, you will be able to log in and see your images. Not only can you see your images, but you can also take more and then easily share with our academic dermatologists if you want their opinion for only $18.
Are my results secure and private?
Yes! The APP requires a secure login just like your bank. Your images may be seen by our academic dermatologists. They will color-code each Dermoscopic image. If you see a RED or Orange spot, you need additional medical care. If all your spots are GREEN, you still need to monitor each spot using the APP to look for changes. The 3D Avatar makes this simple!
Is this Total Body Photography?
Yes, only better! The 3D Avatar makes it much easier and the software helps you find, track, and compare over time. Find new spots when they appear and see if they grow. No change is good! Now you can be certain and be proactive with your care. We call it FBI "Full Body Imaging". It costs only $149 so get yours today!
Can my doctor or I take and add images?
Yes. We sell the same Dermoscopic attachment we use so that you and your doctor can easily compare images and spot changes at the earliest possible time.
Why should I pay for this if my insurance will not reimburse me?
DermEngine is new and yet widely used all around the world. The US healthcare system takes time to recognize new technology that potentially adds costs, even if it may save lives and money. We recommend using your HSA account. Please remember that unless you exceed your deductible for the year, you are paying for the exam that may improve your outcome regardless of coverage! When your employer pays it is a benefit for all!
Why do people avoid seeing the doctor for skin cancer?
We think it is due to the only reimbursable diagnostic test that they have available today. It is called the surgical biopsy and most insurances reimburse the costs of their service. With the MoleScope APP and our noninvasive imaging technology, we can help reduce the need for biopsy by 50% and we increase the diagnosis of thin melanoma by up to 50%! Currently, you must pay for the FBI or ASCS while we collect the evidence to convince them to pay. The average biopsy costs are $500 and it leaves a scar with risks of infection.
Are there other options to pay the costs?
Yes! Introduce us to your employer and when they offer the ASCS or FBI to their employees as a benefit, they take the expense and everyone gets the advantages. Our FBI testing is only $12.50 per month for annual exams. Since most employers are self-insured, they may actually save money with early detection that saves their worker's life!
What are your terms and conditions?
Register and pay with online scheduling via credit card and you pick the available appointment that is most convenient to you. Complete your health-history and sign the consent prior to your appointment to speed up visit. Our goal is 20 minute appointments for all.
Click now to learn how we can benefit the wellness of your patients while creating "passive" income for your practice and not charging more!
Become a "Skin Checker"
Anyone can take charge of their skin health today
Participants help their doctors find skin cancer early
New Price - Only $299
Intensive Skin Cancer Screening
If you have dysplastic nevi syndrome (more than ten moles that need dermoscopy) you need the "ISCS". Includes dermoscopy of all atypical nevi and the added review time by the academic dermatologists.
Help us help you
Employee skin cancer screening is available now
Improve morale when you sponsor a skin cancer screening benefit that shows you care. Deduct the costs as a health benefit that saves you money.
When skin cancer is detected early, the cost to surgically remove the lesion is under $1K
Early detection may save the life of a valuable employee and save millions!
Use the MoleScope APP to find skin cancer at the earliest possible time. Your images are reviewed by experts and you maintain control over your file. Now, you can share the report with images with any local doctor and we will help them to reduce biopsies and improve the detection of melanoma in-situ by 50%!
Your employees can register online and schedule their ASCS at a convenient local office for a private screening. DermDetect will provide you with the tools to educate your employees on Intelligent Dermatology. Teledermatology is one click with the APP and your baseline study provides the reader with all the images so they can provide you with the best treatment advice.
Advanced Skin Cancer Screening (ASCS)
ASCS is pain-free and takes only 15-30 minutes including Full Body Imaging (FBI) with A.I. to help find changes in size, shape, color, or most suspicious of all, a new spot!
Learn all about the ASCS here
Your dermoscopy images are reviewed by an academic dermatologist at OHSU
Secure access to a powerful workstation so only your doctors and you can see your skin images
The most advanced web-based solution and you control it on an APP
OHSU uses color-codes to identify lesions for follow-up. Not a diagnosis
You are a participant for a reason! The academic dermatologists at OHSU will assign a color to each spot. Use the 3D Avatar to locate a spot and then click on it to see the clinical image next to the dermoscopy image. Note the color of the spot. Green = Routine Follow-up. The other colors have meaning too.
RED = Immediate attention
Green (normal annual follow-up); Orange (virtual biopsy with reflectance confocal microscopy, or short term 3-4 week dermatoscopy follow-up); Red (immediate attention from a healthcare provider is recommended – e.g., physical biopsy(shave/punch)); Black (lesion was already removed but remains in the history); and Blue (lesion image quality is insufficient and needs to be retaken).
What do they mean?
Double-check with your doctor before they biopsy
If you have any spot that has been color-coded "RED" you need to see your local medical professional as soon as possible. Most appointments are 2-6 weeks after the ASCS.
DermDetect will help train your doctor to use "SmartSnap" on the DermEngine workstation. In only 1-2 minutes they can capture a new image of the RED spot and look for changes with you. Side-by-side or using the "Flicker" with overlay makes it easy to see if the lesion has changed. No change may delay a biopsy! If you see the change it confirms the need to have one now!
Double-check is SDI~
Sequential Dermoscopy Imaging is SDI and you can only do it when you have had the ASCS or ISCS. SDI is easily performed by your doctor prior to their decision to biopsy.
Look for change the easy way with the powerful DermEngine "Intelligent Dermatology" workstation.
DermDetect will give your doctor training and access for FREE. (You paid the cost with the ASCS!)
Now during your next visit, you and your doctor can look for changes together in only a few minutes!
The literature says that you can have melanocytic cells and if they are stable or not growing, you may be able to leave it alone.
Obviously, if you see change, do something. Your doctor will love ASCS with "Double-check".
DermEngine is powered by DermDetect with Certified Dermographers
Intelligent dermatology imaging, documentation, and analysis of skin conditions
Meet our team
Dermographers have been trained by our academic dermatologists to screen you for suspicious spots and take high-resolution images of your skin and manage the DermEngine so that they can color-code and your doctor can improve your care.
ASCS is Not a Diagnosis - It is a medical record
Dermographer - Oregon
Retired Navy Corpsman - 20 years distinguished service - now focused on your care and positive outcomes!
Dermographer - California
I will carefully check your skin and take high-resolution digital images for our academic dermatologist to review.
Sancy Leachman, M.D., Ph.D.
Co-founder of the ASCS
Thank you for training our dermographers!
Alexander Witkowski, MD, Ph.D.
Assistant Professor of Dermatology
Director, Skin Cancer Imaging
The virtual biopsy is now available at OHSU thanks to Sancy Leachman, MD, Ph.D.
President - Co-founder DermDetect
We all deserve access to the very best technology and people. Together we can reduce the mortality and morbidity rates or skin cancer in the USA.
Neil Box, Ph.D.
Clinical Advisor - Colorado
A lifetime commitment to reducing melanoma mortality and morbidity.
COO - Co-founder DermDetect
Experienced is point-of-care services that connect the experts to the people and places that need it most.